Journal of Antibiotics 1996-08-01

Microbial conversion of EM574 and EM523, gastrointestinal motor stimulating agents.

Y Funabashi, S Hakoda, N Inatomi, K Koyama, S Tanida, S Harada, Z Itoh, S Omura

Index: J. Antibiot. 49(8) , 802-10, (1996)

Full Text: HTML

Abstract

EM574 exerts gastrointestinal motor stimulating (GMS) activity even after being converted to its metabolites P1 and P2 in dogs. These metabolites were isolated from dog liver using a series of chromatographic procedures. Their structures were determined to be the 15- and 14-hydroxyl derivatives of EM574, respectively, by spectral analysis. Large scale preparation by microbial transformation was investigated for further evaluation of the metabolites, because the amounts obtained by oxidation with dog liver homogenate were limited. Three strains of actinomycetes, Amycolatopsis tolypophorus IFO 13151, Dactylosporangium variesporum IFO 14104 and Nocardia capreola IFO 12847, were found to have the aiming oxidative potency. HPLC analysis of the crude extracts from these three cultures showed that the bioactive metabolites, EM574 P1 and P2 were produced. They were isolated from the culture broth with the other bioactive products EM574 P3 and P4. These bioactive products were prepared by large scale cultivation. EM574 P3 and P4 showed GMS activity comparable to that of EM574 P1 and P2. The structures of EM574 P3 and P4 were elucidated by spectral analysis and found to be the 3"-O-demethyl derivatives of EM574 P2 and EM574, respectively. Moreover, the absolute configuration at the C14 position of P2 was determined to be R by spectral analysis of the 6-membered cyclic carbonate of EM574 P2.


Related Compounds

Related Articles:

Sensitive high-performance liquid chromatographic determination of EM523, a new erythromycin derivative, in human plasma and urine with ultraviolet detection using column switching.

[J. Chromatogr. A. 616(1) , 144-50, (1993)]

Comparison of the motor-stimulating action of EM523, an erythromycin derivative, and prostaglandin F2 alpha in conscious dogs.

1993-10-01

[Jpn. J. Pharmacol. 63(2) , 209-17, (1993)]

EM523L, a nonpeptide motilin agonist, stimulates gastric emptying and pancreatic polypeptide secretion.

1996-01-01

[Peptides 17(6) , 895-900, (1996)]

Functional characterization of neural and smooth muscle motilin receptors in the chicken proventriculus and ileum.

1997-08-15

[Regul. Pept. 71(2) , 87-95, (1997)]

In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.

2007-01-01

[Pharmacology 79(3) , 137-48, (2007)]

More Articles...